WO2005052182A3 - A method of analyzing plasma membrane protein content of cells - Google Patents
A method of analyzing plasma membrane protein content of cells Download PDFInfo
- Publication number
- WO2005052182A3 WO2005052182A3 PCT/IL2004/001085 IL2004001085W WO2005052182A3 WO 2005052182 A3 WO2005052182 A3 WO 2005052182A3 IL 2004001085 W IL2004001085 W IL 2004001085W WO 2005052182 A3 WO2005052182 A3 WO 2005052182A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- plasma membrane
- cells
- protein content
- membrane protein
- present
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Biophysics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52488503P | 2003-11-26 | 2003-11-26 | |
US60/524,885 | 2003-11-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005052182A2 WO2005052182A2 (en) | 2005-06-09 |
WO2005052182A3 true WO2005052182A3 (en) | 2005-07-07 |
Family
ID=34632938
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL2004/001085 WO2005052182A2 (en) | 2003-11-26 | 2004-11-25 | A method of analyzing plasma membrane protein content of cells |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2005052182A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112480235B (en) * | 2020-12-14 | 2022-07-15 | 上海交通大学 | Bioactive peptide SGSAAWDDSAGGAGGQGLRVTAL, and preparation method and application thereof |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10254601A1 (en) | 2002-11-22 | 2004-06-03 | Ganymed Pharmaceuticals Ag | Gene products differentially expressed in tumors and their use |
DE10341812A1 (en) * | 2003-09-10 | 2005-04-07 | Ganymed Pharmaceuticals Ag | Differentially expressed in tumors gene products and their use |
DE102004024617A1 (en) | 2004-05-18 | 2005-12-29 | Ganymed Pharmaceuticals Ag | Differentially expressed in tumors gene products and their use |
EP1790664A1 (en) | 2005-11-24 | 2007-05-30 | Ganymed Pharmaceuticals AG | Monoclonal antibodies against claudin-18 for treatment of cancer |
US7879799B2 (en) | 2006-08-10 | 2011-02-01 | Institute For Systems Biology | Methods for characterizing glycoproteins and generating antibodies for same |
WO2013167153A1 (en) | 2012-05-09 | 2013-11-14 | Ganymed Pharmaceuticals Ag | Antibodies useful in cancer diagnosis |
WO2023049789A2 (en) * | 2021-09-24 | 2023-03-30 | Nitto Denko Corporation | Yeast cells with reduced propensity to degrade acrylic acid |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002100892A1 (en) * | 2001-05-29 | 2002-12-19 | Regents Of The University Of Michigan | Systems and methods for the analysis of proteins |
-
2004
- 2004-11-25 WO PCT/IL2004/001085 patent/WO2005052182A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002100892A1 (en) * | 2001-05-29 | 2002-12-19 | Regents Of The University Of Michigan | Systems and methods for the analysis of proteins |
Non-Patent Citations (3)
Title |
---|
BLEDI YANIV ET AL: "PROCEED: A proteomic method for analysing plasma membrane proteins in living mammalian cells.", BRIEFINGS IN FUNCTIONAL GENOMICS & PROTEOMICS, vol. 2, no. 3, October 2003 (2003-10-01), pages 254 - 265, XP002327557, ISSN: 1473-9550 * |
BLONDER JOSIP ET AL: "Enrichment of integral membrane proteins for proteomic analysis using liquid chromatography-tandem mass spectrometry", JOURNAL OF PROTEOME RESEARCH, vol. 1, no. 4, July 2002 (2002-07-01), pages 351 - 360, XP002327558, ISSN: 1535-3893 * |
WASHBURN MICHAEL P ET AL: "Large-scale analysis of the yeast proteome by multidimensional protein identification technology", NATURE BIOTECHNOLOGY, vol. 19, no. 3, March 2001 (2001-03-01), pages 242 - 247, XP002327559, ISSN: 1087-0156 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112480235B (en) * | 2020-12-14 | 2022-07-15 | 上海交通大学 | Bioactive peptide SGSAAWDDSAGGAGGQGLRVTAL, and preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
WO2005052182A2 (en) | 2005-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004063362A3 (en) | Cell cycle progression proteins | |
BRPI0412845A (en) | herpes virus, use of a virus, pharmaceutical composition, and method of treating a tumor in an individual in need thereof | |
WO2008039769A3 (en) | Methods and devices for analyzing small rna molecules | |
WO2003093469A3 (en) | Methods for delivering nucleic acid molecules into cells and assessment thereof | |
WO2002084250A3 (en) | Methods for mass spectrometry detection and quantification of specific target proteins in complex biological samples | |
WO2004044168A8 (en) | Genetically encoded fluorescent reporters of kinase, methyltransferase, and acetyl-transferase activities | |
WO2007041520A3 (en) | Methods for direct protein identification by maldi | |
WO2004018999A3 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer | |
HK1082761A1 (en) | Circular dna molecule having a conditional origin of replication, process for their preparation and their use in gene therapy | |
WO2003014303A3 (en) | Molecular interactions in cells | |
WO2006101387A3 (en) | Method for interfering with blood coagulation by modulating cross-beta structures fibril formation | |
WO2003048300A3 (en) | Methods of identifying cellular target molecules | |
WO2002086448A3 (en) | Detection of microsatellite instability and its use in diagnosis of tumors | |
NZ578283A (en) | Proteomic profiling method useful for condition diagnosis and monitoring, composition screening, and therapeutic monitoring | |
WO2004111081A3 (en) | Antigenic peptides of sars coronavirus and uses thereof | |
WO2002093129A3 (en) | Methods for analyzing interactions between proteins in live and intact cells | |
WO2005040421A3 (en) | Prognostic and diagnostic markers for cell proliferative disorders of the breast tissues | |
WO2005052182A3 (en) | A method of analyzing plasma membrane protein content of cells | |
WO2004065570A3 (en) | Methods of metallizing nucleic acid molecules and methods of attaching nucleic acid molecules to conductive surfaces | |
WO2007020522A3 (en) | Protein markers for diagnosing of colorectal cancer and use of said markers as drug targets for the treatment of said cancer type | |
WO2008034622A3 (en) | A method of detecting and/or quantifying expression of a target protein candidate in a cell, and a method of identifying a target protein of a small molecule modulator | |
WO2005000335A3 (en) | Use of genes differentially expressed during aging of liver for treatment and diagnosis | |
WO2005082398A3 (en) | Diagnosis of hyperinsulinemia and type ii diabetes and protection against same based on genes differentially expressed in muscle cells | |
WO2009108706A3 (en) | Methods for inhibiting six 1 and eya proteins | |
WO2006063009A3 (en) | Diagnosis of hyperinsulinemia and type ii diabetes and protection against same based on proteins differentially expressed in serum |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |